Cancer - Tscan Therapeutics

Cancer

Status:

Active, open to accrual

ClinicalTrials.gov:

NCT05973487

A Phase 1 Basket Study Evaluating the Safety and Feasibility of T-Plex, Autologous Customized T Cell Receptor-Engineered T Cells Targeting Multiple Peptide/HLA Antigens in Participants with Antigen-positive Locally Advanced (Unresectable) or Metastatic Solid Tumors

Drug

TCR-T cell and Tplex Comibnation therapy

Condition

Treatment of participants with locally advanced (unresectable) or metastatic solid tumors